Stock screener

ASND

Conviction 45HealthcareScan · Thu, Sep 24, 2026
Bullish marubozu

Ascendis Pharma A/S (ASND) closed at $230.74 (+3.41%) on Sep 24, 2026. Its latest daily candle is a bullish marubozu. Price is below its 50-day and below its 200-day moving average. RSI(14) 37, RS Rating 55, -16.8% from its 52-week high, +8.2% year to date. Sector: Healthcare · Biotechnology.

ASND$230.74+3.41%
ResistanceSupportVol 14Insider buyInsider sell
63 bars
2
Vol MA14 1.02M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Ascendis Pharma A/SBiotechnologywww.ascendispharma.com ↗
Price230.74
Change+3.41%
Gap-0.68%
Rel volume1.94×
Avg volume894.59K
Avg $ vol221.26M
SMA 20252.12
SMA 50252.01
SMA 200234.98
Price vs 50-8.44%
Price vs 200-1.80%
MA stackmixed
50/200 cross—
Supertrenddown · 257.21
RSI (14)37
MACD hist-3.61
MACD crossbear · 7d
Stoch %K / %D20 / 15
ADX (14)28
+DI / −DI10 / 31
RSI divergence—
MACD divergence—
ATR %4.33%
ADR %3.97%
52w high277.18
52w low189.74
From 52w high-16.75%
Above 52w low+21.61%
New 52w highNo
SqueezeOff
Bollinger width23.04%
%B0.13
Donchian pos19.56%
Donchian high272.47
Donchian low220.60
AVWAP (52w high)250.94
vs AVWAP high-8.05%
AVWAP (52w low)231.10
vs AVWAP low-0.15%
OBV trendDown
Chaikin MF (20)0.03
Today vs 20d1.94×
Avg vol (14d)1.02M
Avg vol (20d)894.59K
Avg $ vol (20d)221.26M
Market cap14.3B
RS Rating55 / 99
RS 3m (vs SPY)-16.28%
RS 6m (vs SPY)-12.36%
RS line new highNo
Trend template4/8
Technical rank39.2
1 week-3.47%
1 month-8.79%
3 months-11.79%
6 months+4.45%
1 year+18.95%
YTD+8.18%
P/E—
P/B—
P/S—
P/FCF—
EPS—
Div yield—
ROE—
ROA—
Debt/Eq—
Current—
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth—
Price target—
Target upside—
Analyst rating—
Institutional107.35%
Ent. value14.3B
Revenue—
Net income—
Gross profit—
Free cash flow—
IndustryBiotechnology
ExchangeNasdaq
Shares out—
Employees1.19K
ListedMon, Apr 20, 2026
Free float46.55M
Float %75.1%
Short interest4.2M
Days to cover9.5d
Short volume58.0%
Squeeze score69 / 100
Next earnings—
EPS forecast—
Last EPS vs est$3.29 vs $0.78
Last surprise+321.8% beat
Setup gradeC
Conviction45 / 100
Pattern quality—
Tech rank39.2 / 100
Group rank59 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmBullish marubozu

Signal lifecycle

How this symbol has moved through the lanes across 60 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

  1. Broke out
    Jun 30 – Jul 1
    2 scans
  2. Setting up
    Jul 15 – Aug 19
    2 scans

Congress activity

Disclosed STOCK Act trades in ASND

All disclosures →
No recent disclosed trades by Congress in ASND. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ASND · open-market 7 buys · 1 sell

InsiderSideShares
Bodenhoff Mads
SVP & PAO · Ordinary Shares · 2026-09-08
Exercise3K
Bodenhoff Mads
SVP & PAO · Ordinary Shares · 2026-09-08
Sell3K
Bodenhoff Mads
SVP & PAO · Warrants · 2026-09-08
Exercise3K
BIENAIME JEAN JACQUES
Director · Ordinary Shares · 2026-08-14
Buy1.1K
BIENAIME JEAN JACQUES
Director · Ordinary Shares · 2026-08-14
Buy900
SMITH SCOTT THOMAS
EVP & Chief Financial Officer · Ordinary Shares · 2026-06-02
Buy100
BIENAIME JEAN JACQUES
Director · Ordinary Shares · 2026-05-29
Buy100
BIENAIME JEAN JACQUES
Director · Ordinary Shares · 2026-05-29
Buy200
SMITH SCOTT THOMAS
EVP & Chief Financial Officer · Ordinary Shares · 2026-05-29
Buy250
BIENAIME JEAN JACQUES
Director · Ordinary Shares · 2026-05-26
Buy200

SEC filings

EDGAR filings in ASND · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.